📰 Between Feb News
Between Feb News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Between Feb. Real-time updates on events, politics, business and more.
June 13, 2024
1. Significantly more patients in the bimekizumab group than placebo reported improved clinical response at week 16. 2. Treatment-related adverse events were infrequent with one fatality across both treatment groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Hidradenitis suppurativa (HiS) is a chronic inflammatory disease with limited therapeutic options. Bimekizumab, a monoclonal IgG1 antibody that
June 12, 2024
1. Women in the surgical group reported 2.5 times more spontaneous ovulations than in medical therapy. 2. Those assigned to surgery had a higher rate of adverse events, although none led to long-term issues. Evidence Rating Level: 1 (Excellent) Study Rundown: Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility and obesity
May 5, 2024
Market Research Services Limited, the company I head, has done a considerable number of national and constituency polls since we branched out into the political arena in 1989. The success of polling companies is measured by the extent to which...
March 27, 2024
1. Children randomized to the MenA group rather than the Vi-TT group were more likely to be diagnosed with typhoid fever. 2. Overall Vi-TT vaccine efficacy was 78.3% with the highest efficacy seen for children aged 2-4 years. Evidence Rating Level: 1 (Excellent) Study Rundown: Typhoid conjugate vaccines in Africa and Asia have shown high
February 14, 2024
Experts say the high number of large fire incidents can be attributed to a combination of factors such as extreme weather conditions, and disgruntled villagers, along with better preparedness, monitoring, and accountability on the part of the department.
November 29, 2023
1. Colchicine did not significantly reduce the risk of atrial fibrillation or myocardial injury after non-cardiac surgery. 2. Use of colchicine was associated with a higher incidence of non-infectious diarrhea. Evidence Rating Level: 1 (Excellent) Study Rundown: Colchicine is an anti-inflammatory drug that may be used for the management of gout and pericarditis. Patients with
August 10, 2023
1. Mean pain score at 6 weeks was not statistically different between the opioid and placebo groups. 2. Risk of opioid misuse after 52 weeks was higher in the opioid group compared to the placebo group. Evidence Rating Level: 1 (Excellent) Study Rundown: Opioid analgesics are commonly used for acute low back and neck pain,
May 16, 2023
1. Annualized bleeding rate was reduced by 91% in the fitusiran prophylaxis group compared to the bypassing agents on-demand group. 2. 5% of patients in the fitusiran group reported thromboembolic events; there were no deaths. Evidence Rating Level: 1 (Excellent) Study Rundown: Hemophilia is marked by a deficiency in certain coagulation factors that make patients
May 9, 2023
1. Median modified Rankin Scale score at 90 days was lower in the endovascular group, indicating improved outcomes. 2. Symptomatic intracranial bleeding was more prominent in the intervention group than control. Evidence Rating Level: 1 (Excellent) Study Rundown: Previous guidelines support the use of endovascular treatment for patients with anterior circulation artery-related ischemic stroke within
March 21, 2023
A group of oilsands companies have a committee exploring nuclear power as an alternative to burning natural gas in oilsands production.